C07C 225/02
Compounds containing amino groups and doubly—bound oxygen atoms bound to the same
Official title: having amino groups bound to acyclic carbon atoms of the carbon skeleton
C07C225/02 (Compounds containing amino groups and doubly—bound oxygen atoms bound to the same) appears on 391 US grants and 379 published applications in this corpus.
Search patents in C07C- Granted patents
- 391
- Published applications
- 379
- Assignees
- 279
- Inventors
- 1,123
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 10 | 0 |
| 1993 | 8 | 0 |
| 1994 | 8 | 0 |
| 1995 | 13 | 0 |
| 1996 | 15 | 0 |
| 1997 | 7 | 0 |
| 1998 | 10 | 0 |
| 1999 | 11 | 0 |
| 2000 | 9 | 0 |
| 2001 | 12 | 0 |
| 2002 | 7 | 11 |
| 2003 | 7 | 8 |
| 2004 | 6 | 15 |
| 2005 | 4 | 11 |
| 2006 | 6 | 20 |
| 2007 | 8 | 10 |
| 2008 | 9 | 25 |
| 2009 | 13 | 15 |
| 2010 | 12 | 17 |
| 2011 | 11 | 13 |
| 2012 | 8 | 15 |
| 2013 | 13 | 20 |
| 2014 | 21 | 24 |
| 2015 | 23 | 33 |
| 2016 | 22 | 14 |
| 2017 | 14 | 21 |
| 2018 | 9 | 15 |
| 2019 | 15 | 20 |
| 2020 | 10 | 11 |
| 2021 | 8 | 17 |
| 2022 | 11 | 9 |
| 2023 | 6 | 11 |
| 2024 | 9 | 7 |
| 2025 | 7 | 9 |
| 2026 | 6 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for synthesizing enantiopure (S)-methadone, (R)-methadone, racemic (R,S)-methadone and related analogue substances22 Sep 2026US 12,741,927 B2
- Formamide monomers and polymers synthesized therefrom22 Sep 2026US 12,741,928 B2Wisconsin Alumni Research Foundation
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Structurally modified opioids for prevention and treatment of diseases and conditions26 May 2026US 12,637,411 B2Mggm LLC
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid19 May 2026US 12,629,421 B2Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Compound and use thereof10 Sep 2026US 2026/0263391 A1Benethera (Shaoxing) Biotechnology Co., Ltd.
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid6 Aug 2026US 2026/0224704 A1Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Substituted Hydroxystilbene Compounds and Derivatives, Synthesis and Uses Thereof23 Jul 2026US 2026/0209152 A1Kynan Duke IP, LLC
- Bio-renewable polymers and uses thereof18 Jun 2026US 2026/0167750 A1The Regents of the University of California
- Methods and materials for increasing level of phosphorylated ampk protein21 May 2026US 2026/0138955 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
Most cited
By later US patents
- Photoactivatable water soluble cross-linking agents containing an onium group198US 5,714,360 ABSI Corporation · 1998
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Ligands for metals and improved metal-catalyzed processes based thereon143US 6,307,087 B1Massachusetts Institute of Technology · 2001
- Modified release formulations of a bupropion salt139US 7,569,610 B2Biovail Laboratories International S.R.L. · 2009
- Modified release formulations of a bupropion salt139US 7,569,611 B2Biovail Laboratories International S.R.L. · 2009